Dr. Christian Traichel

Christian heads up the German Corporate/M&A group and focuses his practice on corporate transactions and corporate law. He supports clients as an experienced negotiator in complex national and cross-border M&A transactions, joint ventures and restructurings. His many years of experience are characterized by factual and goal-oriented negotiation and project management.

He advises leading companies from Germany and abroad and has extensive experience in assisting his clients from North America, Japan and France with transactions in Germany. Christian is a long-standing key contact partner of Taylor Wessing at the World Law Group and has been active there for many years in various functions, including as President.

CV

Since 1999 Partner, Taylor Wessing

2006 – 2008 Lecturer, Munich Business School

2005 – 2008 Lecturer, CDTM Institut der Münchener Universitäten (LMU and TU)

Carrière

Since 1999 Partner, Taylor Wessing

2006 – 2008 Lecturer, Munich Business School

2005 – 2008 Lecturer, CDTM Institut der Münchener Universitäten (LMU and TU)

Formation

1999 Qualification as specialist lawyer for Tax Law

1996 Admitted as a lawyer, Munich

1995 Second state examination, Munich

Publications

Fremdfinanzierung für den Mittelstand, Alternativen zum Bankkredit (co-author), in C.H.Beck Verlag, 2014 , p. 161 – 186, 208 - 219, together with Dr. Albrecht von Beauvais

Das Handbuch für Familienunternehmen - Eine Schriftensammlung (co-author ), in: Reihe Alphazirkel Publikationen, 2012

Know-how – Schwer zu fassen transkript Spezial Recht & Patente, Nr.3, 2011, p. 42 f., together with Dr. Dietrich Kamlah

Mitarbeiterbeteiligung an Biotech-Unternehmen, in: Going Public Sonderausgabe Biotechnologie, 2006, p. 58 f.

Mezzanine Finanzierung (co-author), in: C.H. Beck Verlag 2006, p. 197 – 214, 231 – 243, together with Dr. Albrecht von Beauvais

Wissenstransfer bei Biotechdeals, in: Finance Magazine, p. 22 f., together with Dr. Dietrich Kamlah

European requirements set forth in the EU Takeover Directive and their impact on German takeover law (in Japanese), in: Journal of the Japanese Institute of International Business Law, Vol. 33 N° 11, 2005, together with Dr. Florian Wagner

Vertrauliche Informationen - Der besondere Umgang mit sensiblen Daten bei Transaktionen im Biotech-Bereich, in: Going Public Sonderausgabe Biotechnologie, 2005, p. 160 f.

Die Reform des französischen Zwangsvollstreckungsrechts (loi n°91-650 vom 9. Juli 1991; décret n°92-755 vom 31. Juli 1992), in: Gieseking Verlag, 1995

Groupes & Associations

Vereinigung für Gesellschaftsrecht

Langues étrangères

Prix et distinctions

JUVE Handbook 2024/2025

Featured

The Best Lawyers™ in Germany 2024

JUVE Handbook 2023/2024

Experience

Advising Mitel on its transaction to acquire Unify from Atos

We have advised Mitel, a global leader in business communications, on its transaction to acquire Unify, the Unified Communications and Collaboration (UCC) and Communication and Collaboration Services businesses (CCS) of the Atos group.

Press release

Mark Barron

Dr. Christian Traichel

Gilles Amsallem

Elinor Picton

Dr. Rebekka Krause

Dr. Christian Dietz

Marc André Gimmy

Dr. Klara Pototzky

Dr. Michael Kieffer

Sebastian Rünz, LL.M. (Toronto)

Dr. Adrian Birnbach, LL.M. (Stellenbosch)

Dr. Marco Hartmann-Rüppel, Dipl.-Volkswirt

Dr Bert Kimpel

Dr. Nicolai Wiegand, LL.M. (NYU)

Dr. Jan Phillip Rektorschek

Taylor Wessing conseille Lifento sur les engagements ESG dans les baux et des plans CAPEX ambitieux pour l'efficacité énergétique

Taylor Wessing conseille Lifento, le fonds français spécialisé dans l'immobilier de santé, sur les engagements ESG dans les baux et des plans ambitieux de CAPEX pour l'efficacité énergétique. Alors que le marché de l'investissement en immobilier de santé se concentre sur le "S" (social) de "ESG", Lifento améliore continuellement l'efficacité énergétique de ses actifs immobiliers. Taylor Wessing conseille Lifento depuis son entrée sur le marché sur l'acquisition de ses propriétés liées au secteur médical, paramédical ou pharmaceutique et en matière de gestion d'actifs, conformément à la stratégie ESG de Lifento.

Johannes Callet, Lic. en Droit

Dr. Joachim Mandl

Adrian Bergenroth, Lic. en Droit

Kathleen Munstermann-Senff, LL.M. (Medizinrecht)

Dr. Christian Traichel